Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7241 results

Sort By:

Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples from Colorectal Cancer Patients

Study ID: NCT00899626
Start Date: 2002-06
End Date: 2045-10
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

5000

Intervention / Treatment
Sponsor

Vanderbilt University Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG

Study ID: NCT05773326
Start Date: 2023-05-15
End Date: 2028-05
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

12

Intervention / Treatment

Tmsirolimus

Sponsor

Nader

Source: clinicaltrials.gov

Share:
Add to list

Living Well With Lymphoma

Study ID: NCT06047626
Start Date: 2024-03-07
End Date: 2028-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

68

Intervention / Treatment

Fatigue Reduction Diet

General Health Curriculum

Sponsor

University of Michigan Rogel Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Study of LY2880070 and Gemcitabine in People With Ewing Sarcoma,Ewing-Like Sarcoma, and Desmoplastic Small Round Cell Tumor

Study ID: NCT05275426
Start Date: 2022-03-02
End Date: 2026-03-02
Study Type

Interventional

Study Phase

Phase2

No. of Participants

24

Intervention / Treatment

Ly2880070

Gemcitabine

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Addressing Genomic Disparities in Cancer Survivors

Study ID: NCT06073626
Start Date: 2024-07-31
End Date: 2027-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

428

Intervention / Treatment

Relational agent (RA) / Chatbot

Enhanced Usual Care (EUC)

Sponsor

Rutgers, The State University of New Jersey

Source: clinicaltrials.gov

Share:
Add to list

Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma

Study ID: NCT02203526
Start Date: 2014-08-14
End Date: 2027-06-15
Study Type

Interventional

Study Phase

Phase1

No. of Participants

93

Intervention / Treatment

Isavuconazole

Teddi

Rituximab

Cytarabine

Put it

Ibrutinib (Arms 2, 3 and 4)

Methotrexate

Ibrutinib (Arm 1 - Closed with Amendment G)

Ibrutinib (Arm 4)

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial

Study ID: NCT06069726
Start Date: 2024-03-21
End Date: 2027-01-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

80

Intervention / Treatment

Atezolizumab

Sponsor

Duke University

Source: clinicaltrials.gov

Share:
Add to list

Transrectal Ultrasound Robot-Assisted Prostate Biopsy

Study ID: NCT02871726
Start Date: 2021-11-24
End Date: 2026-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

483

Intervention / Treatment

Then-robot

TRUS biopsy

Sponsor

Johns Hopkins University

Source: clinicaltrials.gov

Share:
Add to list

Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T

Study ID: NCT06784726
Start Date: 2025-07-15
End Date: 2033-04-11
Study Type

Interventional

Study Phase

Phase2

No. of Participants

27

Intervention / Treatment

Odronextamab

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

Chimeric Antigen Receptor T-Cell Therapy

Computed Tomography

Leukapheresis

Lumbar Puncture

Positron Emission Tomography

Administration questionnaire

Biopsy

Sponsor

University of Washington

Source: clinicaltrials.gov

Share:
Add to list

Creation of an Infrastructure to Support Delivery of mHealth Interventions for Cancer Patients

Study ID: NCT06909357
Start Date: 2025-03-28
End Date: 2026-03
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

90

Intervention / Treatment

Quitline Treatment (QT)

App-based Treatment (mHealth)

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Source: clinicaltrials.gov

Share:
Add to list